Repligen Corp. (RGEN)

116.87 -0.91 (-0.77%) USD  |  NASDAQ  |  Apr 06, 14:11
More

Repligen EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Masimo Corp. Upgrade
Orthofix Medical, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade
Tandem Diabetes Care, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade